DSM-Firmenich
€96.16Change from previous close: +0.06%Absolute change: +€0.06
At a glance
- Revenue growth
- −0.22%
- 2025 vs 2024
- Net margin
- -12.0%
- 2024: 2.8%
Financial data
Amounts in millions of EUR; per-share values in EUR; shares in millions.
| Item | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Operating cash flow | 1,445 | 1,778 | 1,265 | 965 | 1,427 |
| Depreciation and amortization | 899 | 931 | 980 | 632 | 646 |
| Capital expenditure | -628 | -645 | -555 | -506 | -433 |
| Investing cash flow | 505 | -252 | -726 | 876 | 208 |
| Financing cash flow | -2,752 | -1,334 | -820 | -645 | -984 |
| Dividends paid | -659 | -660 | -157 | -345 | -266 |
| Share repurchases | -1,181 | -706 | -256 | -210 | -165 |
| Debt issued | 764 | 871 | 15.0 | 51.0 | 49.0 |
| Debt repaid | -669 | -733 | -629 | -107 | -567 |
| Effect of exchange rates | -72.0 | 19.0 | -18.0 | -2.0 | 39.0 |
| Net change in cash | -874 | 211 | -299 | 1,194 | 690 |
| Free cash flow | 817 | 1,133 | 710 | 459 | 994 |
| Levered free cash flow | -32.1 | 352 | 178 | -666 | 1,090 |